Cite

    Zhou, L. et al. (2019). Physiologically based pharmacokinetic modelling to predict exposure differences in healthy volunteers and subjects with renal impairment: Ceftazidime case study. Basic & clinical pharmacology & toxicology. 125 (2), pp. 100-107. [Online].